Cataract
Conditions
Interventions
Experimental group:Implantation of multifocal intraocular lens (PMEA60)
Control group:Implantation of multifocal intraocular lens (AT LISA tri 839MP)
Sponsors
Eye Hospital of Wenzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) Aged 18 to 85 years, male or female; (2) Patients who are expected to undergo phacoemulsification and intraocular lens implantation; (3) LOCS III nuclear grade = 4; (4) The expected refractive power of the intraocular lens to be expected is +5.0D~+32.0D; (5) The best corrected distance visual acuity is less than 0.5 (decimal visual acuity); (6) Be able to understand the purpose of the clinical trial, participate voluntarily and sign the informed consent form by the patient himself or his legal guardian, and be able to complete the postoperative follow-up on time.
Exclusion criteria
Exclusion criteria: (1) Corneal endothelial cell count is less than 2000 cells/mm2; (2) Patients with preoperative fasting blood glucose >=8.3mmol/L; (3) There is a history of trauma that affects visual function, history of intraocular surgery or history of refractive corneal surgery; (4) Patients with strabismus, amblyopia or nystagmus; (5) Patients concomitant with other eye diseases judged by the investigator to be unsuitable for phacoemulsification and multifocal intraocular lens implantation. (6) Other circumstances judged by the investigator to be unsuitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Corrected distance visual acuity;Distance-corrected intermediate visual acuity;Distance-corrected near visual acuity; | — |
Countries
China
Contacts
Public ContactAyong Yu
Eye Hospital of Wenzhou Medical University
Outcome results
None listed